Protect margin.
Measure the cost of payer friction .
Specialty drug authorizations are the largest source of avoidable revenue loss - visible delay, rework, denials, & reimbursement risk. HaloPA gives finance & rev cycle leaders payer-level visibility & workflow intelligence to identify where intervention can protect margin & accelerate access.
Know what is affecting cash.
Turn payer friction into financial intelligence.
Measure authorization performance before relying on assumptions about denials, staffing, or cash impact.
Prevent avoidable denials
Identify missing evidence, payer requirements, & documentation gaps earlier, before they create downstream denial and rework.
Find the long-tail cases
Average turnaround hides cases that consume weeks. Surface delayed authorizations before they become exceptions no one is watching.
Measure payer performance
Compare turnaround, denials, peer-to-peers, & escalation patterns by payer, plan, provider, and regimen.
Stop low-value rework
See repeated denials, resubmissions, & escalation activity so teams can intervene instead of spending labor on the same unresolved problem.
Quantify administrative cost
Measure staff time across preparation, follow-up, appeals, & peer-to-peers to identify where automation produces the greatest return.
Connect PA to cash
Link authorization activity with your own A/R & reimbursement data to determine where payer friction is actually affecting financial performance.
Run the numbers live.
Try the calculator or book a 15-minute demo with your CFO.
Book a Call →